semaglutide and liver disease might be a key for breaking the vicious cycle of metabolically associated fatty spectrum? Semaglutide treats MASH liver disease

Weight loss with Semaglutide varies by individual, but many patients begin to see results within the first few weeks of treatment

The mechanisms underlying these cardioprotective effects are not fully elucidated but likely involve multiple pathways

This is why results are gradual but tend to be lasting with consistent supplementation

10.1016/S0301-2115(03)00368-3 8 BannaiS

Drawing on recent pieces by Nassir Ghaemi and others, I asked how nosology, the ICD, insurance, and treatment would change and what we might lose if we narrow our view of suffering

This can greatly reduce the cost and provide weight loss from the two mechanisms together